Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07774819
PHASE1/PHASE2
Spatially Fractionated Radiotherapy for Tumor Treatment
Sponsor: Xu Zhi-yuan
View on ClinicalTrials.gov
Summary
To explore the efficacy and toxicity of spatially fractionated radiotherapy in the treatment of tumors.
Official title: Spatially Fractionated Radiotherapy for Bulky or Refractory Solid Tumors: Efficacy and Toxicity
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
126
Start Date
2024-12-19
Completion Date
2028-12
Last Updated
2026-08-19
Healthy Volunteers
No
Conditions
Interventions
RADIATION
spatially fractionated radiotherapy
spatially fractionated radiotherapy
Locations (1)
The University of Hong Kong - Shenzhen Hospital
Shenzhen, Guangdong, China